| Inhalation delivery for the treatment and prevention of COVID-19 infection BB Eedara, W Alabsi, D Encinas-Basurto, R Polt, JG Ledford, ... Pharmaceutics 13 (7), 1077, 2021 | 59 | 2021 |
| Spray-dried inhalable powder formulations of therapeutic proteins and peptides BB Eedara, W Alabsi, D Encinas-Basurto, R Polt, HM Mansour AAPS PharmSciTech 22 (5), 185, 2021 | 32 | 2021 |
| Nose-to-brain delivery of therapeutic peptides as nasal aerosols W Alabsi, BB Eedara, D Encinas-Basurto, R Polt, HM Mansour Pharmaceutics 14 (9), 1870, 2022 | 25 | 2022 |
| Development and validation of a rapid high-performance liquid chromatography–tandem mass spectrometric method for determination of folic acid in human plasma A Zayed, R Bustami, W Alabsi, T El-Elimat Pharmaceuticals 11 (2), 52, 2018 | 21 | 2018 |
| Organic solution advanced spray-dried microparticulate/nanoparticulate dry powders of lactomorphin for respiratory delivery: Physicochemical characterization, in vitro aerosol … W Alabsi, FA Al-Obeidi, R Polt, HM Mansour Pharmaceutics 13 (1), 26, 2020 | 18 | 2020 |
| Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried … W Alabsi, MF Acosta, FA Al-Obeidi, M Hay, R Polt, HM Mansour Pharmaceutics 13 (8), 1278, 2021 | 13 | 2021 |
| Bioequivalence of losartan/amlodipine fixed dose combination tablets (Losanet AM) compared with concomitant administration of single components of losartan and amlodipine … R Bustami, S Khasawneh, W Absi, H Feddah, M Mroueh, E Daccache, ... | 8 | 2015 |
| Pulmonary Drug Delivery BB Eedara, W Alabsi, D Encinas-Basurto, R Polt, D Hayes, SM Black, ... Organelle and molecular targeting, 227-278, 2021 | 5 | 2021 |
| Bioequivalence of a fixed dose combination of desloratadine/betamethasone tablets (Oradus Beta) in healthy human volunteers R Bustami, S Khasawneh, W Absi, H Feddah, M Menassa, E Daccache, ... J. Bioequiv. Availab 8, 233-241, 2016 | 4 | 2016 |
| Synthesis of alamandine glycoside analogs as new drug candidates to antagonize the MrgD receptor for pain relief W Alabsi, T Jaynes, T Alqahtani, L Szabo, D Sun, TW Vanderah, ... Medicinal Chemistry Research 31 (7), 1135-1146, 2022 | 3 | 2022 |
| Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032 BB Eedara, B Manivannan, W Alabsi, B Sun, C Curiel-Lewandrowski, ... International journal of molecular sciences 24 (21), 15515, 2023 | | 2023 |
| PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease MI Sulaiman, W Alabsi, L Szabo, M Hay, R Polt, TM Largent-Milnes, ... International Journal of Molecular Sciences 24 (19), 15007, 2023 | | 2023 |
| Synthesis, Comprehensive Characterization, and Development of Therapeutic Peptides and Glycopeptides for Targeted Respiratory Drug Delivery as Inhalation Aerosols W Alabsi The University of Arizona, 2021 | | 2021 |
| Glycopeptide drugs from endogenous peptides violate all of Lipinski's rules and penetrate the BBB L Szabo, C Apostol, W Alabsi, T Jaynes, M Heien, J Streicher, T Falk, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
